ClinicalTrials.Veeva

Menu

The Effect of a Mobile Application on Enhancing Pulmonary Rehabilitation After Lung Cancer Surgery

N

National Cheng Kung University

Status

Not yet enrolling

Conditions

Telerehabilitation
Lung Cancer
Pulmonary Rehabilitation

Treatments

Behavioral: RehabLung mobile application
Other: Healthcare interactive Web Platform
Behavioral: Lung cancer postoperative standard care

Study type

Interventional

Funder types

Other

Identifiers

NCT06600503
A-ER-111-055

Details and patient eligibility

About

The goal of this clinical trial is to investigate the effect of a mobile application intervention on postoperative lung rehabilitation. The main purposes of this study are:

  1. To understand the effectiveness of the pulmonary rehabilitation mobile application in improving lung function.
  2. To assess the feasibility of the pulmonary rehabilitation mobile application in post-surgery rehabilitation care.

Researchers will compare the intervention group (using the pulmonary rehabilitation mobile application) to the usual care group to determine if the mobile application is effective in lung surgery rehabilitation.

Participants will join the study immediately after providing informed consent and will continue for up to 7 weeks post-surgery. Participants will be randomly allocated to either the intervention group or the control group. Both groups will receive regular pulmonary rehabilitation during their hospital stay (1 day before surgery and 2 to 3 days after surgery). Researchers will guide participants in the intervention group to use the mobile application for pulmonary rehabilitation exercises throughout the study period. Participants in the usual care group will receive health education and an exercise guide before discharge. Participants will undergo three study assessments: at baseline (within 1 week after enrollment), post-surgery (week 5), and at follow-up (week 8).

Enrollment

36 estimated patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age over 20 years
  • primary diagnosis of lung cancer at any stage and type
  • referral to lung cancer resection by thoracotomy or videothoracoscopy
  • ability to understand and consent to the trial procedures
  • conscious and cognition intact

Exclusion criteria

  • included adjuvant treatments (chemotherapy or radiotherapy)
  • previous history of thoracic surgery
  • neurological and/or musculoskeletal comorbidities
  • visual or hearing impairment
  • acute respiratory illness

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

36 participants in 2 patient groups

application inttervention group
Experimental group
Description:
The experimental group will receive standard postoperative care, including chest rehabilitation, a mobile application for remote self-training every day after surgery, and an interactive healthcare web platform for health education.
Treatment:
Other: Healthcare interactive Web Platform
Behavioral: RehabLung mobile application
Usual care group
Active Comparator group
Description:
The usual care group will receive standard postoperative care, including chest rehabilitation and an interactive healthcare web platform for health education
Treatment:
Behavioral: Lung cancer postoperative standard care
Other: Healthcare interactive Web Platform

Trial contacts and locations

0

Loading...

Central trial contact

Hsin-lun Yang, MS.; Kun-Ling Tsai, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems